Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / PI3

PI3

Basics

Aliases:
This biomarker is also known as:
  • Elastase-specific inhibitor,
  • Elafin,
  • WAP3,
  • SKALP,
  • protease inhibitor 3, skin-derived (SKALP),
  • MGC13613,
  • cementoin,
  • ELAFIN,
  • WAP four-disulfide core domain protein 14,
  • WFDC14,
  • ESI,
  • peptidase inhibitor 3, skin-derived,
  • skin-derived antileukoproteinase,

View in BioMuta

Description…

ELAFIN, a secreted protein, is a neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. ELAFIN contains a WAP-type four-disulfide core (WFDC) domain, and is thus a member of the WFDC domain family. Expression of the ELAFIN gene is upgulated by bacterial lipopolysaccharides and cytokines.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: PI3

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.

Announcement